World Evidence, Pricing and Access Congress Europe 2026

World Evidence, Pricing and Access Congress Europe is a European congress focused on pharmaceutical market access, pricing, evidence and payer topics.

The 2026 edition takes place at RAI Congress Centre in Amsterdam, covering market access and pricing, rare diseases, HTA and payer dynamics, reimbursement models, affordability, and health economics and outcomes research for pharma, biotech, payer and HTA stakeholders.

Access StrategyDrug PricingReimbursement

Covers pharmaceutical market access, pricing strategy, reimbursement models and affordability for commercialization, access and payer engagement teams.

HTAPayersValue Evidence

Focuses on health technology assessment, payer decision-making, value evidence and access review for HTA bodies, payers and pharma access teams.

Orphan DrugsPatient AccessPayment Models

Addresses rare disease therapies, orphan drug access, payment models and patient access with pharma, research and policy payer stakeholders.

HEORReal World EvidencePoster Area

Covers health economics and outcomes research, real-world evidence and poster exchange to support value demonstration and access decisions.

Overview

Introduction

World Evidence, Pricing and Access Congress Europe is a European congress focused on pharmaceutical market access, pricing, evidence and payer topics.

- 2026年展会数据 -

1,500

Visitors (人)

Product Zones

Gallery

Organizer

Terrapinn Holdings Ltd supports Solar & Storage Live London event operations, commercial enquiries and event services. Its UK office is located at Wren House in London.

The information contained herein is derived from publicly disclosed sources provided by the organizer. Independent verification is advised.